University of Bologna, Bologna, Italy.
IRCCS Policlinico di S.Orsola, Bologna, Italy.
Bone Joint J. 2020 Nov;102-B(11):1567-1573. doi: 10.1302/0301-620X.102B11.BJJ-2020-0127.R1.
The aim of this study was to report the results of three forms of reconstruction for patients with a ditsl tibial bone tumour: an intercalary resection and reconstruction, an osteoarticular reconstruction, and arthrodesis of the ankle.
A total of 73 patients with a median age of 19 years (interquartile range (IQR) 14 to 36) were included in this retrospective, multicentre study.
Reconstructions included intercalary resection in 17 patients, osteoarticular reconstruction in 11, and ankle arthrodesis in 45. The median follow-up was 77 months (IQR 35 to 130). Local recurrence occurred in eight patients after a median of 14 months (IQR 9 to 36), without a correlation with adequacy of margins or reconstructive technique. Major complications included fracture of the graft in ten patients, nonunion of the proximal osteotomy in seven, and infection in five. In the osteoarticular group, three of 11 patients developed radiological evidence of severe osteoarthritis, but only one was symptomatic and required conversion to ankle arthrodesis. Functional evaluation showed higher values of the Musculoskeletal Tumour Society (MSTS) and American Orthopaedic Foot and Ankle Society (AOFAS) scores in the intercalary group compared with the others.
Preservation of the epiphysis in patients with a distal tibial bone tumour is a safe and effective form of limb-sparing treatment. It requires rigorous preoperative planning after accurate analysis of the imaging. When joint-sparing resection is not indicated, ankle arthrodesis, either isolated tibiotalar or combined tibiotalar and subtalar arthrodesis, should be preferred over osteoarticular reconstruction. Cite this article: 2020;102-B(11):1567-1573.
本研究旨在报告三种胫骨骨肿瘤重建方法的结果:节段切除和重建、骨关节重建和踝关节融合。
回顾性多中心研究共纳入 73 例患者,中位年龄 19 岁(四分位距 14 至 36)。
重建包括 17 例节段切除、11 例骨关节重建和 45 例踝关节融合。中位随访时间为 77 个月(四分位距 35 至 130)。局部复发 8 例,中位时间为 14 个月(四分位距 9 至 36),与切缘是否充分或重建技术无相关性。主要并发症包括 10 例移植骨骨折、7 例近段骨切开不愈合和 5 例感染。在骨关节组中,11 例中有 3 例出现严重骨关节炎的影像学证据,但只有 1 例有症状,需要转换为踝关节融合。功能评估显示,节段切除组的肌肉骨骼肿瘤学会(MSTS)和美国矫形足踝协会(AOFAS)评分高于其他两组。
保肢治疗是胫骨骨肿瘤患者安全有效的治疗方法。在进行准确的影像学分析后,需要进行严格的术前规划。当不适合关节保留切除时,应首选踝关节融合术,无论是单纯距下关节融合还是距下关节和跗骨间融合。